Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEMF Therapy for the Management of Diabetes in Obese Patients (ProMise): A Randomized Controlled Trial

NCT04183543 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT04183543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04183543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEMF Therapy for the Management of Diabetes in Obese Patients (ProMise): A Randomized Controlled Trial
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Unknown status
Start date
January 30, 2020
Completion date
December 31, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 2 diabetes